3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
8
OTHER
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Breast Neoplasms
38
Neoplasm Metastasis
9
Brain Neoplasms
6
Stomach Neoplasms
3
Colorectal Neoplasms
3
Advanced Breast Cancer
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasms
2
Neoplasm, Residual
2
Meningeal Carcinomatosis
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Cancer With Brain Metastasis
2
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Inflammatory Breast Neoplasms
1
HER2-positive Breast Cancer
1
HER2-negative Breast Cancer
1
HER2 Overexpression
1
Glioblastoma
1
Gastric Adenocarcinoma
1
Drug-Related Side Effects and Adverse Reactions
1
Colonic Neoplasms
1
Breast Cancer Metastatic
1
Adenocarcinoma Of Esophagus
1
Interventions
Carboplatin
330
Pemetrexed
266
Cisplatin
234
Docetaxel
195
Paclitaxel
182
Radiotherapy
181
Erlotinib Hydrochloride
153
pembrolizumab
147
Gemcitabine
147
Bevacizumab
125
Drug Therapy
121
Radiosurgery
115
Nivolumab
112
osimertinib
92
durvalumab
88
Gefitinib
67
atezolizumab
63
Vinorelbine
63
Surgical Procedures, Operative
62
Magnetic Resonance Spectroscopy
54
anlotinib
42
Immunotherapy
42
Taxes
39
Blood Specimen Collection
39
Ipilimumab
38
130-nm albumin-bound paclitaxel
38
Specimen Handling
36
Immune Checkpoint Inhibitors
35
Radiation
34
Albumin-Bound Paclitaxel
33
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Non-Small-Cell Lung
×
trastuzumab deruxtecan
×
Clear all
NCT07428044
2026-02-23
HERCULES
Memorial Sloan Kettering Cancer Center
Phase 2
Recruiting
14 enrolled
NCT06250777
2026-02-09
ELPIS
Yonsei University
Phase 2
Enrolling by invitation
27 enrolled